📢 BREAKING NEWS! We have made it into the prestigious MedTech Innovator 2023 Cohort, comprising of only the top #medtech startups! With a rigorous acceptance rate of just 5%, we are honored to be recognized among the best in the industry. medtechinnovator.org/worlds-largest…

Bonjour, Paris!🗼 Amazing opportunity to try out Sentante in Paris, and it was an absolute game-changer! Working alongside our partners at Veranex was an absolute pleasure. Together, we pushed the boundaries of what's possible and achieved remarkable milestone🚀

🌉 San Francisco - the perfect meeting point for groundbreaking ideas and transformative collaborations! We had the chance to engage in partnering sessions and connect with other exciting companies in the field at Medtech Innovator Startup Showcase 2023! MedTech Innovator

Proud moment at Society of Robotic Surgery | SRS annual meeting! Tomas took the stage to present Sentante unveiling some of the most remarkable features of Sentante. Thank you Vipul Patel, MD and Adnan H. Siddiqui, MD for the invitation.

Sentante - revolutionary endovascular robot for minimally invasive surgery empowers doctors to perform a complete intervention from a distance, bridging the gap in remote areas or where timely stroke care is not available. Time matters. Distance doesn't.

Sentante announces the closing of a €6 Million funding round led by Practica Capital and EIC fund. The company will use the proceeds from the financing for the planned clinical trial of the endovascular robotic system and preparation of commercial launch.

Our GLP animal study exceeded expectations and showcased extraordinary results. This milestone marks an important step forward in our journey! Veranex